AxoGen, Inc.AXGNNASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 127 | 139 | 159 |
| Gross Profit | 104 | 109 | 122 |
| Operating Income | -25 | -30 | -21 |
| Net Income | -27 | -29 | -22 |
| EBITDA | -21 | -23 | -13 |
| EPS Diluted | -0.65 | -0.69 | -0.51 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 33 | 15 | 31 |
| Total Current Assets | 127 | 98 | 88 |
| Total Assets | 208 | 195 | 197 |
| Total Current Liabilities | 24 | 24 | 30 |
| Total Liabilities | 95 | 94 | 101 |
| Total Equity | 113 | 101 | 96 |
| Total Debt | 67 | 67 | 69 |
| Net Debt | 35 | 52 | 38 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | -13 | -16 | -6 |
| Capital Expenditure | -28 | -21 | -15 |
| Free Cash Flow | -42 | -37 | -21 |
| Stock-Based Comp | 11 | 16 | 14 |
| Net Change in Cash | -17 | -17 | 15 |